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Summary.-Plasma membranes from 6 spontaneously metastasizing and 4 non-
metastasizing rat mammary carcinomata were isolated by discontinuous sucrose
density gradient centrifugation of microsomal pellets. The starting microsomal
fraction contained 40-50%o plasma membranes as determined by the levels of 5'-
nucleotidase activity, with a negligible amount of nuclear (1%), mitochondrial (5%o) and lysomal (7%o) contamination. Five distinct fractions (F1-F5) were banded at
densities 1 09, 1 13, 1 15, 1-17 and 1-21 at 25°C, in addition to a pellet (F6) obtained by
centrifuging at 76,000 g for 17 h. The fractions Fl through F5, all contained various
concentrations of membranous structures, while the pellet (F6) contained only
amorphous materials as evidenced by electron microscopy. The F3 fraction at the
gradient 1 15 had the highest specific as well as total activity of the plasma membrane
marker enzyme, with aggregates of the least contaminated plasma membranes in
vesicular forms. This fraction also had the lowest specific activity for glucose-6-
phosphatase (smooth ER marker) and for ,B-D-glucuronidase (lysomal marker), and
therefore was considered to be the " cleanest " plasma membrane fraction. When
the activity of 4 additional plasma membrane marker enzymes, i.e., alkaline phos-
phatase, phosphodiesterase I, nucleotide pyrophosphatase and alkaline ribonuclease
was determined in the same F3 fraction, their levels were significantly lower in every
metastasizing tumour than in the non-metastasizing ones, with the enzyme activity
decreasing in direct proportion to the metastasizing capacity. On the other hand,
the marker enzymes were high in all non-metastasizing tumours, with the activity
seemingly increasing with the immunogenicity of tumour cells. There was no
significant difference between the 2 groups of mammary tumours in the levels of
sialic acid, hexosamine, phospholipid or cholesterol in the plasma membranes.
Thus, the level of plasma membrane marker enzymes is considered an accurate
indicator for metastasizing capacity in the rat mammary tumour system.
IN EARLIER studies (Kim and Pickren,
1974; Kim et al., 1975), it was demon-
strated that the level of various plasma
membrane marker enzymes correlated
roughly with the amount of membrane
bound glycoproteins or glycocalyx and
the immunogenicity of rat mammary
tumour cells, and, inversely, with their
antigen shedding property and meta-
stasizing capacity. Since subcellular con-
taminants tend to interfere with an
accurate quantitation of tumour cell
plasma membranes, we have directed our
efforts towards developing a method
whereby the plasma membranes of rat
mammary tumour cells, free of con-
taminations, canbeprepared reproducibly.
This paper describes an improved method
for isolation of plasma membranes and
also confirms and extends our earlierS. K. CHATTERJEE, U. KIM AND K. BIELAT
observations on the biochemical charac-
teristics of spontaneously metastasizing
mammary tumour cells.
MATERIALS AND METHODS
Six well established, spontaneously meta-
stasizing rat mammary carcinomata (TMT-
50, STMT-058, MT-449, SMT-077, TMT-081
and SMT-2A) and 4 histologically and
growth rate-wise matched non-metastasizing
ones (MT-W9B, MT-W9A, MT-66 and MT-
100) maintained in the highly inbred W/Fu
female rats were used for this study. The
standardized tumour transplantation pro-
cedure is described elsewhere (Kim et al.,
1975). Their metastasizing capacity was
rated arbitrarily as: negative (0), occasional
or microscopic (0-±), slight (±), moderate
(+), marked (-+-+) and extensive (±+++),
according to the speed of dissemination, the
size of metastatic nodules and the extent
of lymph node and other secondary organ
involvements. TMT-50 metastasized usually
to the lung whereas others involved primarily
lymph nodes. TMT-081 and SMT-2A spread
widely to other parenchymatous organs after
involving most of the lymph nodes in the
body. When the transplanted tumours grew
to 1-2 cm in average diameter, the rats
were killed by ether and fresh tumours
were promptly collected in Petri dishes on
an ice-tray. The connective tissue and
necrotic portions were trimmed off the
tumour, which was quickly minced with a
scalpel or razor blade, and the fragments were
pressed through a fine sieve-tissue press
(Arbor Press by Harvard Apparatus, Co.,
Mills, Ma.). The pressed tissue was col-
lected in an all-glass homogenizer (0-005-
0 007 inch clearance). Three ml of a solution
containing 0-25 mol/l sucrose and 0-1 mmol/l
CaCl2, with its pH adjusted to 8-0 with
tris-HCl, was added for each g of pressed
tumour. The suspensions were homogenized
by one downward stroke of the pestle by
hand. The homogenate was centrifuged at
200 g for 1-10 min depending on the tumour
strain. The supernatant was saved and
the residue was homogenized once more in
the glass homogenizer with an equal volume
of the solution. After the second homo-
genization, more than 90%o of the cells
were disrupted, as verified by the standard
trypan blue dye exclusion test.
Calf thymus DNA, yeast RNA, bovine
serum albumin, glucose-6-phosphate, 5'-ade-
nosine mohophosphate, nicotinamide adenine
dinucleotide (NAD), N-acetyl neuraminic
acid, 2-(p-iodophenyl)-3-(p-nitrophenyl)-5-
phenyl tetrazolium chloride (INT), p-nitro-
phenyl fl-D-glueuronide, p-nitrophenyl phos-
phate and p-nitrophenyl-thymidine-5'-phos-
phate were purchased from Sigma Chemical
Co., St Louis, Mo., cholesterol from Eastman
Kodak Chemicals, Rochester, N.Y. and all
other chemicals were of analytical grade
and obtained from Fisher Scientific Co.,
Fair Lawn, N.J.
Fractionation of subcellular organelles.
Fig. 1 illustrates the step-by-step fractiona-
tion procedure. The nuclear fractions were
sedimented after low speed centrifugation
at 200 g and 1000 g for 5 min each. The
mitochondria were removed from the super-
natant by centrifugation at 7000 g for
15 min. The supernatant was then spun
at 78,000 g for 90 min., and the microsomal
pellet for the sucrose gradient centrifugation
was obtained. The pellet was suspended in
a solution containing 100 mmol/l tris-HCl
(pH 8 0) and 1 mmol/l CaCI2, then 60%
sucrose was added to this (9 : 1 by volume)
and the mixture was stirred with a glass
rod. Ten ml of the mixture was placed in
a cellulose nitrate tube (60 ml capacity)
for the SW 25-2 rotor (Beckman Instruments
Inc., Spinco Division, Palo Alto, Ca.) and
overlayered with 10 ml each of 41% 370%, 33%, 24% and 15% sucrose in 10 mmol/l
tris-HCl (pH 8 0) and 041 mmol/l CaCl2 at
25°C. The sucrose concentration was check-
ed by a hand refractometer (Bausch &
Lomb Inc., Rochester, N.Y.). The discon-
tinuous gradient was centrifuged at 76,000 g
for 17 h. Five distinct bands designated
as Fl, F2, F3, F4 and F5, in addition to the
pellet (F6), were obtained and carefully
collected with pasteur pipettes and their
sucrose concentration adjusted to 0-25 mol/l
with distilled water. Each fraction was
recentrifuged at 78,000 g for 90 min to
bring it down in a pellet form and its protein
concentration was adjusted to 1-2 mg/ml
with 0-25 mol/l sucrose containing tris
and CaCl2. All fractions were stored at
-20°C until they were used.
Enzyme assays-.Succinic dehydrogenase
(EC 1.3.99.1) was chosen for the mito-
chondrial marker and was assayed according
to Pennington's procedure (1961), as modified
by Porteous and Clark (1965). P-D-glucuro-
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FIG. I.-Step-by-step fractionation procedure for plasma membranes of mammary tumours.
Fraction F3 yielded the cleanest plasma membranes.
nidase (EC 3.2. 1 .31) activity was measured
for the lysosomal content by a modification
of the method of Beck and Tappel (1967)
using 2 mmol/l p-nitrophenyl A-D-glucuronide
in 100 mmol/l acetate buffer, pH 4-0 at
370C. The reaction was stopped by the
addition of an equal volume of 0 75 mol/l
Na2CO3. Triton X-100 (0-1O%) was added
to the buffer to activate latent enzymes.
Alkaline phosphatase (EC 3.1 3. 1) and
phosphodiesterase I (EC 3. 1 .4. 1) levels
were determined by measuring the liberation
of p-nitrophenol from p-nitrophenyl phos-
phate (Garen and Levinthal, 1960) and
p-nitrophenyl-thymidine-5'phosphate (Raz-
zell, 1961) respectively. A change of optical
density of 1-5 at 410 [km was considered
as 0-1 ,umol of substrate hydrolysis. 5'-
nucleotidase (EC 3. 1 .3.5) activity was
measured by the method of Michell and
Hawthorne (1965). Glucose-6-phosphatase
(EC 3. 1 .3.9) activity representing the levels
of smooth surfaced endoplasmic reticulum
(SER) was determined by the method of
Swanson (1950), as described by Demus
(1973). Since this enzyme was found to be
unstable in this tumour system, all fractions
were assayed at the same time as soon as
they were isolated. Nucleotide pyrophos- phatase (EC 3.6. 1 .9) was determined accord-
ing to the procedures of Schliselfeld, Eys and Touster (1965) using NAD as the sub-
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strate,andalkalineribonuclease(EC2.7.7. 16)
was measured by the method of Prospero et
al. (1972). All enzyme assays were con-
ducted under optimal conditions and, to
maintain linearity during the assay, either
the enzyme solution was diluted or the
incubation periods were adjusted.
Chemical analyses ofplasma membranes.-
The levels of phospholipid, cholesterol,
sialic acid, hexosamine and hexose in the
isolated plasma membranes of the mammary
tumours were determined by the procedures
described by Bosmann, Hagopian and Eylar
(1968), with slight modifications as follows:
The sample was precipitated with 10%
phosphotungstic acid in 0 5 N HCI, the preci-
pitate was washed twice with 5% trichloro-
acetic acid (TCA), dried at room temperature
overnight and then mixed with 1 ml of
methanol. Twvo ml of chloroform were added
and incubated at 37TC for 20 min. Sub-
sequently, 1 ml of methanol was again added
and the mixture was centrifuged at 3000 g for
15 min. The supernatant was decanted and
the residue washed once again with 2 ml of a
chloroform: methanol (1 : 1) mixture. The
washingswAerepooledwiththesupernatantand
the whole extract was dried at 90-95TC. The
dried extract was dissolved in chloroform
and aliquots were taken for the analysis
of phospholipid and cholesterol. Cholesterol
was measured according to the method of
Searcy, Berquist and Jung (1960) taking
measured volumes over filter paper discs.
For phosphorus determination in the phos-
pholipids, Bartlett's method (1959) was used
after evaporating the chloroform. The resi-
due of chloroform-methanol extraction was
used separately for the assay of sialic acid
(Warren, 1959), hexosamine (Gatt and Ber-
man, 1966) and hexose (Roe, 1955). The
standards used for these assays were crystal-
line KH12PO4 for phosphorus, crystalline
cholesterol for cholesterol, N-acetylneura-
minic acid for sialic acid, galactosamine
hydrochloride for hexosamine, and glucose
for hexose. DNA was used as marker for
nuclear materials and RNA for rough-
surfaced endoplasmic reticulum (RER). The
samples were extracted for nucleic acids
as described by Schneider (1957), except
for the use of perchloric acid instead of
TCA, and RNA was determined by the
orcinol reaction, while DNA was measured
by the diphenylamine method of Giles and
Myers (1965). Yeast RNA and calf thymus
DNA were used as standards. Protein
content was determined by the method of
Lowry et al. (1951) using crystalline albumin
as a standard.
Electron microscopy. The 6 subcellular
fractions from each tumour were fixed in
10% osmium tetroxide in Palade's (1952)
buffer, pH 7-6, dehydrated in graded acetone
and propylene oxide and embedded in
Spurr's (1969) lowN viscosity epoxy resin
(Electron Microscopy Sciences, Fort Wash-
ington, Pa). Sections wAere made through
the pellets on a Porter-Blum MT-2 ultra-
microtome (Ivan Sorvall Co., Norwalk. Conn.).
They were stained w%ith lead citrate and
examined in a Siemens Elmiskop IA electron
microscope at 80 kV.
RESULTS
Subcellular fractionation of tumour cells
The nucleic acid content and specific
marker enzyme activities for the sub-
cellular organelles isolated from a repre-
sentative metastasizing (SMT-2A) and
a representative non-metastasizing (MT-
W9B) tumour are shown in Tables I
and II. Most nuclear material (80%
of DNA) was pelleted at 200 g but the
length of centrifugation varied from 1 to
10 min depending on the tumour. The
nuclear pellet was washed twice with
the homogenization solutioin in order to
recover plasma membranes sedimented
with nuclei and the washings were pooled
with supernatant. However, loss of plas-
ma membranes to the nuclear fraction
was often as much as 3000. An addi-
tional 10-20% of DNA was sedimented
together 'with red blood cells at 1000 g
for 5 min. The red cells remained mostly
intact under the homogenization pro-
cedure and low speed centrifugation.
The pellet at 7000 g for 15 min contained
approximately 400o mitochondria as de-
termined by the marker enzyme succinic
dehydrogenase, and this amounted to
a four-fold enrichment over the homo-
genate. The mitochondrial supernatant
was spun down at 78,000 g for 90 mim
to obtain microsomal material which was
the starting material for gradient centri-
fugation. This microsomal pellet con-
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TABLE I.-Intracellular Distribution of Marker Enzymes and Nucleic Acids in
Non-metastasizing Mammary Tumour MT-W9B
Fraction
Homogenate
Nuclei I
Nuclei II
Mitochondria
Microsomes
Cytosol
Recovery
Protein
mglg
tumour (%)
80-9 (100)
19- 6 (24)
9-0 (11)
6- 6 (8)
11-0 (14)
32- 3 (40)
(97)
DNA
figlmg
protein (%)
40-8 (100)
128-1 (76)
68- 3 (19)
12- 3 (3)
3- 3 (1)
0 (0)
(99)
RNA
jg/mg
protein (%)
48-8 (100)
68-0 (34)
38-1 (9)
34- 2 (6)
152- 0 (42)
20- 8 (17)
(108)
Succinic
dehydro-
genase
S.A.* (%)
0-036 (100)
0-046 (31)
0-038 (12)
0- 175 (40)
0- 015 (6)
0-004 (4)
(94)
fl-D-glucu-
ronidase
S.A. (%)
0-46 (100)
0-52 (28)
0-13 (3)
1-20 (22)
0-24 (7)
0- 43 (38)
(98)
Glucose-
-6-phos-
phatase
S.A. (%)
0-29 (100)
0- 40 (33)
0-37 (14)
0 59 (17)
0- 86 (40)
0 (0)
(105)
5'-nucleo-
tidase
S.A. (%,)
3-7 (100)
3- 8 (25)
2-1 (6)
6-6 (15)
13-6 (50)
0 (0)
(96)
* Specific activity -= ,zmol product converted/h/mg protein.
TABLE II.-Intracellular Distribution of Marker Enzymes and Nucleic Acids in
Metastasizing Mammary Tumour SMT-2A
Fractio(n
Homogenate
Nuclei I
Nuclei II
Mitochondlria
Microsomes
Cytosol
Recovery
Protein
mg/g
tumour (%)
93-3 (100)
20-1 (22)
6-3 (7)
8-9 (9)
15-9 (17)
28 0 (30)
(85)
DNA
iglmg
protein (%)
38-1 (100)
155-5 (88)
57-4 (10)
23- 3 (6)
3-0 (1)
0 (0)
(105)
RNA
fUglmg
protein (%)
52-5 (100)
80- 9 (33)
77-6 (10)
60-2 (11)
106- 8 (35)
16- 3 (9)
(98)
Succinic
dehydro-
genase
S.A.* (0)
0-032 (100)
0-049 (33)
0-063 (13)
0- 138 (40)
0-010 (5)
0-003 (2)
(93)
fl-D-glucu-
ronidase
S.A. (%)
2-16 (100)
2- 32 (23)
2- 33 (7)
5- 60 (25)
0-92 (7)
3-09 (43)
(106)
Glucose-
6-phos-
phatase
S.A. (%)
0-19 (100)
0-29 (33)
0-23 (8)
0 32 (16)
0-36 (33)
0-08 (13)
(104)
5'-nucleo-
tidase
S.A. (%)
0-248 (100)
0- 104 (9)
0- 146 (4)
0- 182 (7)
0- 562 (39)
0- 194 (23)
(82)
* Specific activity ,umol product converted/h/mg protein.
tained about 30-40% of RER (as deter-
mined by RNA levels) and SER (as
measured by glucose-6-phosphatase acti-
vity). It also contained 40-50o of
plasma membranes as determined by the
marker enzyme, 5'-nucleotidase (Tables I
and II) and about equal amounts of
alkaline phosphatase and phosphodies-
terase I activity. It had negligible
amounts of DNA (1%), succinic dehydro-
genase (5%0) and ,-D-glucuronidase (7%).
Electron microscopy of this material
showed that it was rich in vesicular
membranes with only occasional broken
mitochondria and lysosomes, and was
completely free of intact nuclei. Even
this gentle homogenization procedure
broke up many lysosomes, solubilizing
as much as 40%0 of them into the cytosol,
as evidenced by the levels of lysosomal
enzyme, /8-D-glucuronidase activity.
About 20% of intact lysosomes were
sedimented with mitochondria. The ana-
lysis of the subcellular distribution of
marker enzymes and nucleic acids on
other metastasizing and non-metastasiz-
ing mammary tumours showed the dis-
tribution patterns similar to SMT-2A
and MT-W9B.
Isolation of plasma nmenmbranes
Tables III and IV summarize the
distribution of membraneous materials
in the 6 sucrose gradient fractions.
Fraction FI contained less than 1%
protein and only occasional membranous
structures by electron microscopy, while
F2 had considerably more plasma mem-
branes in vesicular form as evidenced
by a relatively high specific activity for
5'-nucleotidase. However, this fraction
was contaminated by considerable
amounts of RER, SER and lysosomes.
F3 had the highest specific activity for
5'-nucleotidase and relatively low levels
of RNA, glucose-6-phosphatase and /?-D-S. K. CHATTERJEE, U. KIM AND K. BIELAT
TABLE III.-Distribution of RNA and Marker Enzymes in Sucrose Gradient
Fractions from NAon-metastasizing Mammary Tumour MT-W9B
p-D-glucuronidase
S.A.* (Oo)
1-59 (4)
0-61 (9)
0-49 (10)
0- 62 (29)
0-33 (39)
0-31 (8)
Glucose-6-
p)hosphatase
SA. (0/ )
:3-69 (3)
:3 -49 (18)
1-33 (10)
1-93 (32)
0-87 (36)
0-17 (2)
RNA
lig/mg
proteini (0)
0) (0))
56- 6 (3)
47- 1 (3)
55-0 (9)
125- 2 (51)
347 :3 (34)
5'-nucleotida.so
S.A. (Oc//)
47-8 (3)
51 i (17)
79.5 (:37)
16-4(17)
9-6 (25) 1]7 (1)
* Specific activity /Lmol product convorte(1/h/mg proteiln.
TABLE IV. Distribution of RNA and Marker Enzymes in Sucrose Gradient
Fractions from Metastasizing Mammary Tumour SMT-2A
Protein
mg/g
tutmour (0)
0-03 (1)
0-79 (13)
0-45 (7)
0- 83 (14)
3 - 32 (55)
0- 60 (10)
fl-D-glucuronid(ase
S.A.* (%)
2- 82 (1)
1-66 (20)
1-42 (10)
1- 82 (23)
0-81 (41)
0-47 (4)
5'-nucleotidase
S.A. (Oo )
1- 71 (0)
1 71 (33)
3-53 (39)
0- 11 (2)
0-29 (24)
0-09 (1)
* Specific activity - limol prodtuct conlverted1/h/mg protein.
glucuronidase, and was packed with
fairly uniform trilaminar plasma mem-
brane vesicles (Fig. 2, 3). Therefore, F3
was considered to be the cleanest plasma
membrane fraction. When tumour cells
were homogenized more vigorously, the
amount of F2 increased, whereas F3
and F4 decreased, indicating that the
plasma membranes were being broken up
into smaller pieces by this procedure.
The fractions F4 and F5 contained much
less plasma membranes and more RER,
SER and lysosomes. F4 had the second
highest specific activity for ,-D-glucuro-
nidase and the most intact lysosomes
(Fig. 4). F5 had the highest protein
content and the second highest RNA
levels, but it was composed of a mixture
of plasma membrane vesicles, SER, RER,
lysosomes and ribosomal particles (Fig.
5). The pellet F6 contained the highest
RNA level and the lowest 5'-nucleotidase
activity. It showed only amorphous par-
ticles in the electron microscopy. No
DNA or succinic dehydrogenase could
be detected in any of these 6 fractions,
indicating that they were free of unclear
or mitochondrial contamination.
Plasma membrane marker enzymes
Since the F3 was the "' cleanest"
plasma membrane fraction representing
a 13-21 fold enrichment over the homo-
genate (Table V), it was used for the
comparative analysis of 5 plasma mem-
brane marker enzymes in the 4 non-
metastasizing and 6 metastasizing mam-
mary tumours. The activity of 5 en-
zymes, i.e., alkaline phosphatase, 5'-
nucleotidase, phosphodiesterase I, nucleo-
tide pyrophosphatase and alkaline ribo-
nuclease, was assayed under optimal
conditions for each enzyme. Table AV
shows that the activity of every marker
enzyme studied was higher in all non-
metastasizing tumours and as the meta-
stasizing capacity increased the enzyme
activities decreased proportionally. The
most marked difference in the enzyme
levels between the highest non-meta-
stasizing tumour and the lowest meta-
stasizing tumour was in alkaline phos-
Density
g/ml at
25 C
1-09
1 13
1- 15
1-17
1- 21
FractioIn
Fl
F2
F3
F4
F5
F6
Protein
mglg
tumour (0)
0-038 (1)
0-222 (6)
0- 311 (9)
0-709 (20)
1- 756 (51)
0-424 (12)
Density
g/ml at
25OC
1-09
1- 13
1-15
1- 17
1-21
Fraction
Fl
F2
F3
F4
F5
F6
Glu.cose-6-
phosphatase
S.A. (o0)
1- 70 (1)
2-20 (41)
0- 80 (8)
1-20 (23)
0-32 (25)
0-10 (1)
RNA
llg/mg
p)rotein (0)
0 (0)
:31- 8 (3)
:36- 4 (2)
77-4 (7)
162-3 (60)
421 -4 (28)
I-0tFIG. 2.-An electron micrograph of plasma membranes in vesicular forms obtained from the
sucrose gradient fraction F3 of spontaneously metastasizing tumour SMT-2A. x 80,000.
FIG. 3. A higher magnification electron micrograph of the fraction F3, similar to Fig. 2, showing
trilaminar plasma membranes. x 160,000.FIG. 4.-An electron micrograph of the fraction F4 ofnon-metastasizing tumour MT-W9B,
showing lysosomes. x 100,000.
FiG. 5.-An electron micrograph of the fraction F5 of non-metastasizing tumour MT-W9B, showing
a mixture of RER, SER, ribosomal particles and plasma membrane vesicles. x 60,000.ANALYSES OF ENRICHED PLASMA MEMBRANE PREPARATIONS
TABLE V.-Activity ofPlasma Membrane Marker Enzymes* in Non-metastasizing
and Metastasizing Mammary Tumours
Tumour
strain
MT-W9B
MT-W9A
MT-66
MT-100
Metastasizing
capacityt
0
0
0
0
TMT-50 0-±
STMT-058 ±-+
MT-449
SMT-077
TMT-081
SMT-2A
++ ±++
Alkaline
phosphatase
153 0±24 0:
(7-6)§
48-0±4-8
(3-2)
17-0±3-9
12-0±2-5
5'-nucleotidase
79-5±8-1
(3-7)
39-0±0- 5
25-3±7-1
34-2±5- 6
21-6±0-6 37-4±1-0
4-2±2-3 21-8±4-1
(1-1)
6-7+2-8 24-3±4-1
0-4±0-3 8- 8±1- 5
0-3±0-2 3-4±1-2
(0.22)
0-4±0-2 3-5±2- 1
(0-03) (0-25)
Phospho-
diesterase I
89-0±21- 0
(5-2)
87-8±5-0
166-0+14-0
48-046-0
(4-2)
59-05-0
517+4-0
26-0±5-1
53±0- 7
3-8±0-5
7-9±1-9
(0 56)
Nucleotide
pyro-
phosphatase
27-0±8-0
24-0±6-0
32-0±2-7
16-0±1-7
16-2±0-5
13-8±0- 5
13-9±2-3
3-9±0-4
44-0±04
Alkaline
ribonuclease
265-3±40-0
192-6±12- 7
118-5±23-8
50-0±5-4
54-0±6-2
76-8±10-0
1-6±1- 3
1-2±0-9
7-5±0-7 2-5±1-2
* Expressed in ,umol/h/mg protein, except alkaline ribonuclease which is expressed as change in optical
density at 260 ,um/h/mg protein.
t The metastasizing capacity rated arbitrarily as 0 = negative, 0-+ = occasional or microscopic,
± = slight, + = moderate, + + = marked and + + + = extensive.
$ Mean ± standard deviation, based on 3 separate preparations assayed in triplicate.
§ Enzyme levels in whole cell homogenate.
TABLE VI.-Chemical Composition ofPlasma Membranes*from Non-metastasizing
and Metastasizing Mammary Tumours
Metasta-
sizing
capacityt
0
0
0
+
Sialic acid Hexosamine
0-036±0-0021: 0-182±0-01
(0-01)§ (0-07)
0-028±0-002 0-153+0-02
0-042±0-003 0-151±0-08
0-045±0-002 0-213±0 02
0-042±0-002 0-179±0-05
0-038±0-002 0 121±0-03
SMT-2A + + + 0-035±0-002 0-163+0-03
(0-01) (0.062)
Cholesterol
Hexose Cholesterol Phospholipid Phospholipid
0-419 1-28±0-02 1-883±0-18 0-68
(0-14) (0-36) (0-39)
0-256 0-691±0-03 1-175±0-09 0-59
0-246 0-638±0-07 0 730±0-12 0-87
- 0-519±0-08 0-882±0-07 0-59
0-291 - -
0-417 0-738±0-09 1-212±0-13 0-61
(0.09)
0-319 0-719±0-07 1-145±0-08 0-63
(0-09) (0-18) (0.50)
* Expressed in ,umol/mg protein.
t The metastasizing capacity rated arbitrarily as 0 = negative, ± = slight, + = moderate and
+ + + = extensive.
$ Mean ± standard deviation, based on a single preparation assayed in triplicate.
§ Enzyme levels in whole cell homogenate.
phatase and alkaline ribonuclease, where
the ratios were about 500: 1 and 200: 1
respectively. Other enzymes also dif-
fered by 7-25 times. The possibility
of any stimulatory or inhibitory factors
for these enzymes in either plasma mem-
branes or in the whole cell homogenate
was excluded by mixing a metastasizing
with a non-metastasizing tumour pre-
paration in separate experiments, where
simple additive values were obtained.
Chemical composition ofplasma membranes
Table VI summarizes the major che-
mical composition of plasma membranes
from 4 metastasizing and 3 non-meta-
stasizing mammary tumours. There was
no significant difference between the 2
Tumour
strain
MT-W9B
MT-W9A
MT-66
STMT-058
MT-449
TMT-081
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groups in the content of sialic acid,
hexosamine, hexose, cholesterol and phos-
pholipid, either in the plasma membrane
fraction or in the homogenate. Elevated
cholesterol and phospholipid content and
a high cholesterol-phospholipid ratio are
known to be characteristics of plasma
membranes (Coleman and Finean, 1966;
Touster et al., 1970). The plasma mem-
brane fraction F3 was enriched in these
components from the homogenate by
several fold.
DISCUSSION
Since the functional characteristics
of the plasma membrane associated with
the biological property of tumour cells
must depend to a large extent on the
chemical composition, quantitative ana-
lysis of the components of the isolated
plasma membranes may provide impor-
tant clues for molecular mechanisms
underlying cellular functions. In the
preparation ofplasma membrane fractions
from mammalian cells, the degree of
purity is determined by the level of
specific activity of plasma membrane
marker enzymes and of impurity by
the level of marker enzymes for other
subcellular organelles. However, some
of the markers, e.g., glucose-6-phospha-
tase, are unstable in some tissues (Demus,
1973) and the preparatory approach
often leads to misleading interpretation.
Therefore, an analytical approach with
a balance sheet of the marker activities
is essential (De Pierre and Karnovsky,
1973). The procedure adopted here is
a commonly used one involving sub-
cellular fractionation followed by density
gradient separation of the fraction con-
taining the highest proportion of plasma
membranes. The conditions of homo-
genization, centrifugal fractionation and
the density of sucrose gradients were
specially adopted for this rat tumour
tissue after repeated preliminary trials.
Under our homogenization conditions
more than 90% of the cells were dis-
rupted but 20-30% of the lighter sub-
cellular fractions were often entrapped
in the nuclear pellet. Sediments at dif-
ferent stages of centrifugation were not
washed because washinginvariably caused
further fragmentation. In order to fur-
ther maintain the integrity of subcellular
organelles, CaCl2 was incorporated in
the homogenization medium. The purity
ofeachsubcellularfraction wasdetermined
by specific markers for individual or-
ganelles and recovery of each constituent
was more than 90%. Plasma membranes
were isolated from the microsomal fraction
which contained the highest concentra-
tion of 3 plasma membrane marker
enzymes, i.e., 5'-nucleotidase, alkaline
phosphatase and phosphodiesterase I, and
had negligible amounts of nuclear and
mitochondrial contamination. At low
speed centrifugation, 80% of cellular
DNA was sedimented and under electron
microscopy the nuclear pellet contained
mostly intact nuclei. In the microsomal
pellet, therefore, we had to cope only
with 3 major possible contaminants, i.e.,
SER (glucose - 6 - phosphatase), RER
(RNA) andlysosomes (,B-D-glucuronidase).
In the sucrose gradient fractions, glucose-
6-phosphatase andfi-D-glucuronidase were
also enriched several fold compared with
the homogenate, suggesting that they
were mostly membrane bound. Never-
theless, the F3 fraction contained the
highest specific activity for plasma mem-
brane enzymes and the lowest for SER
and lysosomal marker, indicating that
this fraction was the " cleanest " plasma
membrane preparation. It was enriched
with 5'-nucleotidase 14-20 fold compared
with the homogenate, with glucose-6-
phosphatase 4-5 fold, and with ,B-D-
glucuronidase 06-1 0 fold. Assuming
that glucose-6-phosphatase and /,-D-glu-
curonidase are the exclusive markers for
SER and lysosomes, our plasma mem-
brane preparations are contaminated with
5% lysosomes and 20-30% ER mem-
branes. However, this ER contamina-
tion probably is an over-estimation for
at least part of the glucose-6-phosphatase
activity may be derived from nonspecific
phosphatases, in spite of using tartrate
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in the assays. Since repeated washings
with 0 25 mol/l sucrose did not change
the specific activity of constituent en-
zymes appreciably,'contamination by cyto-
sol is also considered minimal.
The most striking observation in the
analyses of 5 different plasma membrane
marker enzymes in the F3 fraction from
6 spontaneously metastasizing and 4 non-
metastasizing mammary tumours was
that the specific activity of all 5 enzymes
was much higher in the non-metastasizing
ones, and the enzyme activities decreased
proportionally as the metastasizing capa-
city increased (Table V), confirming our
earlier observations (Kim and Pickren,
1974; Kim et al., 1975). Therefore, plas-
ma membrane marker enzymes seem to
be an accurate indicator for metastasizing
capacity of tumour cells in this experi-
mental tumour system and have prog-
nosticating value. This observation is
currently being tested in human breast
cancer. Since all 5 enzymes are deficient
in spontaneously metastasizing tumours
which are also lacking in glycocalyx, the
biochemical changes representing or re-
sponsible for the biological differences
between these 2 tumour groups are not
likely to be localized in any specific loci
of the cell surface, for they may be
spread throughout the plasma membranes.
Plasma membrane marker enzymes in
non-metastasizing tumours are entirely
sedimentable with the membrane particu-
late, while at least 20% of them are
solubilized in the cytosol of the meta-
stasizing tumours as observed earlier
(Kim et al., 1975). Furthermore, the
proportion of F2 fraction is greater in
the metastasizing tumours, indicating that
the plasma membranes of spontaneously
metastasizing tumours are more fragile.
It should be noted that the levels of
other constituent enzymes between the
2 groups of tumours are similar, except
for glucose-6-phosphatase and 8l-D-glucu-
ronidase. The former is very labile in
this tumour system and results are pre-
sented with reservations. On the other
hand, as observed earlier (Tunis, Kim
and Carruthers, 1973; Kim and Pickren,
1974), the 2-3 fold increase of lysosomal
enzymes, including /-D-glucuronidase and
acid phosphatase, in the metastasizing
tumours is remarkable and its significance
with respect to the antigen shedding
property needs to be investigated.
These studies confirm earlier observa-
tions (Kim et al., 1975) and lend support
to our hypothesis that loss of glycocalyx
and shedding of cell surface antigens
by spontaneously metastasizing mammary
tumour cells result in loss of activity
of plasma membrane marker enzymes.
Further analyses of glycoproteins, glyco-
lipids, carbohydrate metabolism with re-
spect to glycosyl transferase and glyco-
sidase activities in the plasma membranes
are being carried out to elucidate the
biochemical mechanism of antigen shed-
ding and acquisition of metastasizing
property by malignant tumour cells.
This work was supported in part
by Contract NO1-CB-23864 from the
Breast Cancer Program Coordinating
Branch, Division of Cancer Biology and
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